In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
November 7th, 2005 | 46 | No |
24815-24-5; C06540; Rescinnamine
24815-24-5; D00198; Rescinnamine (JAN/INN); Tsuruselpi S (TN)
24815-24-5; Prestwick_558; Rescinnamin
3,4,5-Trimethoxycinnamic acid, methyl reserpate
3,4,5-Trimethoxycinnamoyl methyl reserpate
3,4,5-Trimethoxycinnamoyl methyl reserpate; Trimethoxy cinnamoyl reserpate de methyl
3,4,5-Trimethylcinnamic acid, ester with methyl reserpate
3,4,5-Trimethylcinnamoyl methyl reserpate
4-25-00-01323 (Beilstein Handbook Reference)
Methyl 18-O-(3,4,5-trimethoxycinnamoyl)reserpate
Methyl reserpate 3,4,5-trimethoxycinnamic acid ester
Methyl Trimethoxycinnamoylreserpate
O-(3,4,5-Trimethoxy-trans-cinnamoyl) methyl reserpate
Reserpic acid methyl ester 3,4,5-trimethoxycinnamate
Trimethoxy cinnamoyl reserpate de methyl
Trimethoxy cinnamoyl reserpate de methyl [French]
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 5.43 | 3.11 | -48.19 | 2 | 11 | 1 | 119 | 635.734 | 11 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 3.49e-03 g/l | DrugBank-approved |
Therapy | antihypertensive | SMDC MicroSource |
PUBCHEM_PATENT_ID | EP0005365A1; EP0011246A1; EP0033797A1; EP0061186A1; EP0061187A1; EP0107941A1; EP0123948A1; EP0156321A2; EP0156322A2; EP0157409A2; EP0159167A2; EP0159167B1; EP0159168A2; EP0166353A2; EP0166353B1; EP0173990A2; EP0176956A2; EP0176956B1; EP0205511A1; EP024082 | IBM Patent Data |
Patent Database Links | EP1815846; EP1829527; EP1829528; EP1884513; GB2264710; WO2007112581 | ChEBI |